Valuation: RaySearch Laboratories AB

Market Cap 6.17B 652M 564M 526M 483M 909M 62.18B 922M 2.42B 31.09B 2.45B 2.39B 104B P/E 2026 *
23.1x
P/E 2027 * 18.9x
Enterprise Value 6.34B 670M 579M 541M 496M 934M 63.88B 947M 2.49B 31.95B 2.51B 2.46B 106B EV / Sales 2026 *
4.54x
EV / Sales 2027 * 3.8x
Free-Float
80.09%
Yield 2026 *
2.22%
Yield 2027 * 2.65%
1 day+2.30%
1 week+0.39%
Current month+0.39%
1 month-20.90%
3 months-1.36%
6 months+0.15%
Current year-20.24%
1 week 172.8
Extreme 172.8
183.3
1 month 161
Extreme 161
235.8
Current year 161
Extreme 161
237
1 year 161
Extreme 161
300.25
3 years 63.1
Extreme 63.1
369.5
5 years 40.8
Extreme 40.8
369.5
10 years 40.8
Extreme 40.8
369.5
Manager TitleAgeSince
Chief Executive Officer 57 31/12/1999
Director of Finance/CFO 48 26/01/2025
Chief Tech/Sci/R&D Officer 53 27/08/2015
Director TitleAgeSince
Director/Board Member 57 31/12/1999
Chairman 81 17/11/2016
Chairman 87 29/09/2022
Change 5-day change 1-year change 3-year change Capi.($)
+2.30%+0.39% - - 651M
+5.82%+13.10%-18.31%+18.81% 37.44B
-1.07%+8.55%-42.92%+146.27% 12.99B
+1.06%+0.07%-23.29%+64.66% 5.44B
+5.99%+14.23%+0.24% - 2.49B
+3.31%+2.50% - - 1.84B
+1.80%+4.07%+19.40%-42.77% 1.68B
+0.08%-2.57%-35.37% - 1.02B
+1.98%+6.68%+36.18%+128.08% 915M
-1.36%+1.68%-33.39%-46.62% 833M
Average +1.99%+5.27%-12.18%+44.74% 7.18B
Weighted average by Cap. +3.61%+10.10%-21.78%+49.96%

Financials

2026 *2027 *
Net sales 1.4B 148M 128M 119M 109M 206M 14.07B 209M 548M 7.04B 554M 542M 23.45B 1.63B 172M 149M 139M 128M 240M 16.44B 244M 640M 8.22B 647M 633M 27.38B
Net income 265M 28.01M 24.21M 22.61M 20.75M 39.06M 2.67B 39.62M 104M 1.34B 105M 103M 4.45B 320M 33.82M 29.24M 27.3M 25.06M 47.17M 3.23B 47.84M 126M 1.61B 127M 124M 5.37B
Net Debt 169M 17.86M 15.44M 14.42M 13.23M 24.91M 1.7B 25.27M 66.33M 852M 67.06M 65.61M 2.84B 25M 2.64M 2.28M 2.13M 1.96M 3.69M 252M 3.74M 9.81M 126M 9.92M 9.7M 420M
Logo RaySearch Laboratories AB
RaySearch Laboratories AB (publ) is a Sweden-based medical technology company that develops software for radiation therapy of cancer. It markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Company’s commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.
Employees
465
Date Price Change Volume
07/08/26 SEK 180.50 +1.52% 4,906
06/08/26 SEK 177.80 +1.95% 2,036
05/08/26 SEK 174.40 -1.41% 8,402
04/08/26 SEK 176.90 -0.17% 6,233
03/08/26 SEK 177.20 -2.39% 15,878
Trader
Investor
Global
Quality
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
179.90SEK
Average target price
310.00SEK
Spread / Average Target
+72.32%

Quarterly revenue - Rate of surprise